Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation

Objectives: To systematically review the effectiveness and cost-effectiveness of palivizumab for the prevention of respiratory syncytial virus (RSV) in children and examine prognostic factors to determine whether subgroups can be identified with important differences in cost-effectiveness. Data sour...

Full description

Bibliographic Details
Main Authors: D Wang, C Cummins, S Bayliss, J Sandercock, A Burls
Format: Article
Language:English
Published: NIHR Journals Library 2008-12-01
Series:Health Technology Assessment
Subjects:
Online Access:https://doi.org/10.3310/hta12360